More on IDXX

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (+9.1% Growth)
- Ratings (5.4 Score)
- Holders
- Stock Splits

Financials

Income Statement
Balance Sheet
Cash Flow Statement

Upcoming Events

- Earnings (8/4/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

IDXX Balance Sheet

Click line-items for a historical chart and %
Cash and cash equivalents 150.07M
Accounts receivable, net of reserves of $3,187 in 2011 and $2,828 in 2010 204.7M
Inventories, net 168.47M
Deferred income tax assets 0
Other current assets 63.46M
Total current assets 828.1M
Property and equipment, net 349.66M
Goodwill 180.95M
Intangible assets, net 47.57M
Other long-term assets, net 94.09M
Total long-term assets 672.27M
TOTAL ASSETS 1.5B
Accounts payable 44.13M
Accrued liabilities 202.07M
Line of credit 488M
Current portion of long-term debt
Current portion of deferred revenue 26.01M
Total current liabilities 760.21M
Deferred income tax liabilities 20.57M
Long-term debt, net of current portion 599.14M
Long-term deferred revenue, net of current portion 30.87M
Other long-term liabilities 34.59M
Total long-term liabilities 685.18M
Total liabilities 1.45B
Commitments and Contingencies (Note 13) 0
Common stock, $0.10 par value: Authorized: 120,000 shares; Issued: 98,835 and 97,968 shares in 2011 and 2010, respectively 10.31M
Additional paid-in capital 994.3M
Deferred stock units: Outstanding: 119 and 118 units in 2011 and 2010, respectively
Retained earnings 488.03M
Accumulated other comprehensive income -35.08M
Treasury stock, at cost: 42,004 and 40,657 shares in 2011 and 2010, respectively -1.41B
Total IDEXX Laboratories, Inc. stockholders' equity 54.85M
Noncontrolling interest 136K
Total stockholders' equity 54.99M
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY 1.5B